Improvements in benign prostatic hyperplasia-specific quality of life with dutasteride, the novel dual 5α-reductase inhibitor

M. P. O'Leary, Claus Roehrborn, G. Andriole, C. Nickel, P. Boyle, K. Höfner, Gillian Barnett

Research output: Contribution to journalArticlepeer-review

70 Scopus citations

Fingerprint

Dive into the research topics of 'Improvements in benign prostatic hyperplasia-specific quality of life with dutasteride, the novel dual 5α-reductase inhibitor'. Together they form a unique fingerprint.

Medicine & Life Sciences